Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.85NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.85NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.65NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.65NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.65NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BG.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BG.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BG.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.61NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.61NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.61NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.23NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.23NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.74NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.74NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.74NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BM.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BM.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BM.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.28NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.28NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.62NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.62NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.62NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.24NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.24NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.13.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.13.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.13.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.28NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.28NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used